Some individuals may utilize GLP-1 (glucagon-like peptide-1) drugs, sometimes called GLP-1 receptor agonists, to help them decrease weight
What the study was about The researchers analysed electronic health records from the University of Pennsylvania Health System, comparing more than 12,000 adults prescribed GLP-1 receptor agonists with patients taking other diabetes drugs like SGLT-2 and DPP-4 inhibitors between 2019 and 2024
Spot potential trends & changes using data from your tests and connected devices
If further clarification or additional information is needed, our clinical team will reach out to you
Nooms data shows members in its microdosing program can lose up to 11 pounds in 30 days and up to 17 pounds in 60 days, Egler says
They boost insulin secretion in response to glucose while inhibiting glucagon release, aiding in blood sugar control without causing hypoglycemia